Cedex bioprocess analyzer

Request for Information (RFI)

Cedex Bio Bioprocess Analyzer

General Information:

This is an RFI as defined in FAR 15.201(e) to identify vendors that can provide the capabilities described herein.   

This RFI is issued solely for information and planning purposes and does not constitute a solicitation.  All information received in response to this RFI will be treated as business confidential information.  Nonetheless, submitters should properly mark their responses if the information is confidential.  Responses to the RFI will not be returned.  Responses to this notice are not offers and cannot be accepted by the Government to form a binding contract.  Responders are solely responsible for all expense associated with responding to this RFI.

RFI Response and due date: 2 May 2023

Instructions to Responders:

Responses from all capable and qualified sources are encouraged to respond to this request. 

White papers should adhere to the following formatting and outline instructions:

1.   All submissions shall be made electronically and be in one of the following formats: Microsoft Word or Adobe PDF.

2. Cover Page (1page)

• Title
• Organization
• Responders technical and administrative points of contact (names, addresses, phone, fax number and email addresses)
• Topic area(s) addressed

3.   Completed Attachment 1 and Attachment 2.  Please note that the response shall provide sufficient technical data to determine how you fully meet the requirements as specified in Attachment 2. 

Please note that responses are due no later than 2 May 2023, 12:00pm, Eastern.  The preferred method of submission is via email, SUBJECT: Cedex Bio Bioprocess Analyzer.  The point of contact for this action is Dawn Jennings, Contract Specialist, dawn.v.jennings.civ@health.mil.  Only electronic responses are requested.  No evaluation letters and/or results will be issued to the respondents.  At this time no solicitation exists; therefore, please do not request a copy of the solicitation.  NO PHONE CALLS PLEASE.  It is the responsibility of any potential offeror to monitor this site for the release of any solicitation or synopsis.

Background/Overview:  

The purpose of this requirement is to supply WRAIR with a bioprocess analyzer for use in GMP manufacturing process development activities..

In order to achieve the objectives of providing scalable and GMP manufacturable processes for vaccines and biologics, WRAIR provides process development support to include development and characterization of new processes for bacterial and mammalian cell culture. In order to provide a well defined repeatable process WRAIR requires a bioprocess analyzer capable of measuring cell culture conditions throughout the growth process to assess osmolality, glutamine/glutamate, glucose, lactate, IgG, and other metabolites to assess the health of the culture.

For the purpose of this market research, below is an outline of a Brand Name product and that has been identified to meet the requirement and to better assist potentinal vendors in understanding the need.  Potential vendors are to use table below for informational purpose only and is expected to provide its own capability as a response to this RFI.  

Software Licenses

Product Name                              Product Code          Quantity

CEDEX Bioprocess Analyzer         6395554001                   1

Freight                                                                                   1